Member Info for Chazzy2

Muggins, you're the sort of person who if you won the lottery would complain about the shape of your winning lottery ticket. Is the glass ever half full for you, under any circumstances?

If you have no patience Muggins then AIM is not for you. Look at small cap stocks generally - they have been decimated in recent months. Are you going to pin that one on Gerry as well? Maybe global warming, inflation and Ukraine is all Gerry's fault too??

There's plenty going on in the background. Commercialisation takes time and the pandemic has delayed business across the board, but it's all taking shape nicely. Read a few more RNSs and listen to a few more interviews.

Who says they were badly made or unsafe? Pure speculation. The FDA didn't specify.

I personally would rather see a European mark of accreditation replace the current Gold Standard FDA stamp of approval for drugs and medical devices. I have completely lost all faith in the FDA. Look at Polarean as a case in point and the ludicrous reason why its life saving and ground breaking pulmonary imaging system was rejected. At a time when millions are suffering from long Covid.

Another great interview by Cathal.
https://www.**********.co.uk/articles/cathal-friel-of-open-orphan-discusses-the-results-from-the-world-s-first-covid-19-characterisation-study-1d13638/

£40m Gov contract was it? - thought it was £50m but may I be wrong. Surely now the characterisation study has been proved safe there is no reason why the the Gov can not go ahead with the full study. What surprised me was that Cathal made no mention of this, only mentioned private companies, of which I'm sure there will be many. Am I missing something? Has the Gov stalled on this project?

Great news RNS but no mention of the £ 50m government contract in Cathal's interview. Surely the good results should drive the contract forward now.

Orph not Dvrg. Hvivo apparently were involved in producing the Covid strain for both the Oxford and Hvivo studies back in Sept 2021

Today's article I believe is being conducted by Hvivo. Look at the two articles below. Helen Mcshane is mentioned in both and Andrew Catchpole in the first.

https://www.ox.ac.uk/news/2022-01-26-volunteers-needed-human-challenge-trial-study-immune-response-covid-19
https://www.politico.eu/article/uk-coronavirus-challenge-trials-volunteers/

With a market cap of £8m and cash of about £3m this gives MSYS an EV of £5m (maths always was my strong point lol!) Revenues this year should be multiples of 2021 revenues with all the international contracts being put in place in so many different applications. 2021 revenues were largely down to the legacy business model. Totally different business model this year. Bargain entry price right now.

Great update and proactive interview Gerry. Well done to yourself and all the team. Looks like every part of the business is growing rapidly, launch of Skin Trust Medical sounds exciting and more news to come this week or next.

Retire, you really can not refrain from insults can you. I am all too aware of Microtox's involvement in the Olympics as I do my research and read RNSs. My point was merely to state that this year DVRG will clearly benefit from the Microtox installations, having acquired Modern water.

I think what is important is the fact that the Microtox technology is being used for water screening at the Olympics - a huge endorsement. The technical differences between the PD units and other units are really neither here nor there.

Gerry's tweet seems pretty clear to me. If you feel so strongly sell up and leave. Being rude achieves nothing accept reflecting badly on the person dishing it out.

When you consider the hoops AGL has had to jump through before commercialisation of its proven Parsortix technology can begin you do wonder how the convicted and disgraced Elizabeth Holmes ever got her failed 'Edison' blood testing machine off the ground. Clearly no testing of the machine was ever properly conducted, certainly no clinical trials or FDA approval and yet hundreds of millions of dollars were invested in her company and commercialisation and usage of the device was permitted. Very strange.

2021 has been a year of substantial progress for DVRG and full credit to Gerry and the team for making it so. The sp sadly does not the reflect this as poor market sentiment towards small cap stocks since June has weighted heavily on the sp of many companies including DVRG. To the astute investor however this now represents a fantastic buying opportunity. DVRG has positioned itself as one a very few life science and environmental health companies with a transformational technology with its ability to monitor in real time pathogens in waste water. DVRG has a substantial global footprint and will next year be rolling out in mass its transformational microtox PD technology across several continents, including China, as well as partnering with China Resources, a company on a par with Pfizer in size. It's Microtox BT breathalyser for the rapid and highly accurate detection of Sars-Cov-2 and other pathogens in humans will similarly be rolled out pending a CE mark. Labskin continues to expand at a phenomenal pace. And then there is Skin Trust Club, launched only months ago but already expanding globally and revolutionising skin care treatment to customers whilst providing skin care manufacturers the data needed to conduct clinical trials - the perfect circle of data utilisation.
DVRG is one of the gems to watch out for in 2022. Don't get left behind.

It's the microtox BT breath test devices you need for the cruise ships, not the PD ones, but they haven't completed the human trials yet.

Best wishes and a very merry Christmas to you too Gerry. I would say most of us shareholders on this board really appreciate your efforts and all your team's hard work throughout the year, and realise that it takes time to really build value in a small cap company. I'm very much looking forward to what I believe will be a transformational year next year for Deepverge.

Zzzzzzzzzzzzzzzzzzzzzzzz!!!